522 (Cefpodoxime 100 mg)
Pill imprint 522 has been identified as Cefpodoxime proxetil 100 mg.
Cefpodoxime is used in the treatment of tonsillitis/pharyngitis; bronchitis; bladder infection; kidney infections; gonococcal infection, uncomplicated (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Cefpodoxime 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 522
- Strength:
- 100 mg
- Color:
- Orange
- Size:
- 11.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Northstar Rx LLC
- National Drug Code (NDC):
- 16714-0211
More about cefpodoxime
Consumer resources
- Other brands: Vantin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
